Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca Proactive uses images sourced from Shutterstock…
Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
The positive opinion is based on results from the Phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials, previously…